Company profile
Callio Therapeutics
Realizing the promise of multi-payload antibody-drug conjugates to improve cancer therapy
- Industry
- Biotechnology Research
- Employees
- 20
- Headquarters
- Seattle, Washington
- Founded
- 2025
- LinkedIn followers
- 4,159
- Office locations
- 2
Callio Therapeutics company summary
Callio Therapeutics is a company in the Biotechnology Research industry, headquartered in Seattle, Washington, founded in 2025. On LinkedIn the company has around 20 employees and 4,159 followers. The company lists 2 office locations. Its listed specialties include dual-payload antibody-drug conjugates.
What technology does Callio Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Callio Therapeutics
Callio Therapeutics is pioneering the next generation of antibody-drug conjugates with a pipeline of dual-payload ADCs designed to overcome treatment resistance and drive deeper, more durable responses. While first-generation ADCs have transformed cancer treatment, most patients ultimately progress and have urgent need for better therapies. Powered by highly adaptable dual-payload technology, backed by top life science investors, and led by an experienced team with a track record of success, Callio Therapeutics is built to deliver better outcomes for patients.
Specialties
Where is Callio Therapeutics located?
Callio Therapeutics lists 2 office locations.
Compare companies similar to Callio Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Callio Therapeutics calliotx.com | Biotechnology Research | 20 | 2025 | Seattle, Washington |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Callio Therapeutics
What does Callio Therapeutics do?
Callio Therapeutics is pioneering the next generation of antibody-drug conjugates with a pipeline of dual-payload ADCs designed to overcome treatment resistance and drive deeper, more durable responses. While first-generation ADCs have transformed cancer treatment, most patients ultimately progress and have urgent need for better therapies. Powered by highly adaptable dual-payload technology, backed by top life science investors, and led by an experienced team with a track record of success, Callio Therapeutics is built to deliver better outcomes for patients.
How many employees does Callio Therapeutics have?
Callio Therapeutics has around 20 employees on LinkedIn.
Where is Callio Therapeutics headquartered?
Callio Therapeutics is headquartered in Seattle, Washington.
Where does Callio Therapeutics have offices?
Callio Therapeutics lists 2 office locations, including Seattle, Washington, US; Singapore, 117525, SG.
When was Callio Therapeutics founded?
Callio Therapeutics was founded in 2025.
Build a lead list from companies like Callio Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.